GlassScriptPhysician profile
Gary K Wilson
NPI 1639249014
$3,717.62
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,037 · 2020: $147 · 2021: $433 · 2022: $1,393 · 2023: $707.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $706.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $613.04 | 2021-2023 | Vraylar |
| Sunovion Pharmaceuticals INC. | $433.50 | 2019-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $348.98 | 2021-2023 | |
| Ironshore Pharmaceuticals INC. | $345.56 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $314.31 | 2019-2023 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Supernus Pharmaceuticals, INC. | $250.25 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $232.81 | 2019-2023 | Invega Sustenna, Invega Trinza |
| Neurocrine Biosciences, INC. | $225.34 | 2019-2023 | Ingrezza |
| Indivior INC. | $201.69 | 2019-2023 | Perseris |
| Teva Pharmaceuticals USA, INC. | $152.60 | 2019-2023 | Uzedy |
| E.R. Squibb & Sons, L.L.C. | $111.10 | 2019 | |
| Almatica Pharma LLC | $92.11 | 2022-2023 | Loreev Xr, Sertraline Hcl |
| Vanda Pharmaceuticals INC. | $83.44 | 2019-2020 | |
| Lundbeck LLC | $69.99 | 2019-2023 | Abilify Maintena |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $56.27 | 2019-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $50.33 | 2019-2022 | |
| Corium, LLC | $41.69 | 2022 | |
| Allergan, INC. | $28.00 | 2019 | |
| Shire North American Group INC | $26.15 | 2019 | |
| Adlon Therapeutics L.P. | $21.90 | 2021 | |
| Eisai INC. | $18.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.